SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-14-009316
Filing Date
2014-05-29
Accepted
2014-05-29 08:47:24
Documents
1
Period of Report
2014-05-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 16837
  Complete submission text file 0001179110-14-009316.txt   18174
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Issuer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1211 LIGHT STREET-#214 BALTIMORE MD 21230
Business Address
Neumayer Matthew Paul (Reporting) CIK: 0001476315 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32966 | Film No.: 14874406